NO980923D0 - Optisk aktivt fenylpyrimidin-derivat som analgetisk middel - Google Patents

Optisk aktivt fenylpyrimidin-derivat som analgetisk middel

Info

Publication number
NO980923D0
NO980923D0 NO980923A NO980923A NO980923D0 NO 980923 D0 NO980923 D0 NO 980923D0 NO 980923 A NO980923 A NO 980923A NO 980923 A NO980923 A NO 980923A NO 980923 D0 NO980923 D0 NO 980923D0
Authority
NO
Norway
Prior art keywords
analgesic
optically active
phenylpyrimidine derivative
active phenylpyrimidine
derivative
Prior art date
Application number
NO980923A
Other languages
English (en)
Other versions
NO980923L (no
Inventor
Malcolm Stuart Nobbs
Sandra Jane Rodgers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO980923D0 publication Critical patent/NO980923D0/no
Publication of NO980923L publication Critical patent/NO980923L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO980923A 1995-09-05 1998-03-04 Optisk aktivt fenylpyrimidin-derivat som analgetisk middel NO980923L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518027.9A GB9518027D0 (en) 1995-09-05 1995-09-05 Pharmacologically active compound
PCT/EP1996/003856 WO1997009317A2 (en) 1995-09-05 1996-09-03 Optically active phenyl pyrimidine derivative as analgesic agent

Publications (2)

Publication Number Publication Date
NO980923D0 true NO980923D0 (no) 1998-03-04
NO980923L NO980923L (no) 1998-05-04

Family

ID=10780172

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980923A NO980923L (no) 1995-09-05 1998-03-04 Optisk aktivt fenylpyrimidin-derivat som analgetisk middel

Country Status (32)

Country Link
US (1) US6124308A (no)
EP (1) EP0879230B1 (no)
JP (1) JPH11512108A (no)
KR (1) KR19990044397A (no)
CN (1) CN1200729A (no)
AP (1) AP640A (no)
AR (1) AR004192A1 (no)
AT (1) ATE203523T1 (no)
AU (1) AU710091B2 (no)
BG (1) BG65102B1 (no)
BR (1) BR9610388A (no)
CA (1) CA2230362A1 (no)
CO (1) CO4750651A1 (no)
CZ (1) CZ65598A3 (no)
DE (1) DE69614150T2 (no)
EA (1) EA000695B1 (no)
ES (1) ES2160834T3 (no)
GB (1) GB9518027D0 (no)
HR (1) HRP960399A2 (no)
HU (1) HUP9901260A3 (no)
ID (1) ID17274A (no)
IL (1) IL123414A0 (no)
IS (1) IS4673A (no)
NO (1) NO980923L (no)
NZ (1) NZ318390A (no)
PL (1) PL325329A1 (no)
SK (1) SK28598A3 (no)
TR (1) TR199800386T1 (no)
TW (1) TW367326B (no)
WO (1) WO1997009317A2 (no)
YU (1) YU49796A (no)
ZA (1) ZA967466B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016212A1 (es) * 1998-04-28 2001-06-20 Astra Ab Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas
EP1085890A1 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Novel sodium channel drugs and uses
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
GB9907965D0 (en) * 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
NZ523851A (en) * 2000-07-21 2004-09-24 Ortho Mcneil Pharm Inc A method for use of carbamate enantiomers in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
CA2439468A1 (en) 2001-02-27 2002-09-06 Teva Pharmaceutical Industries Ltd. New crystal forms of lamotrigine and processes for their preparations
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
EP1496864B1 (en) * 2002-04-23 2007-03-21 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
CA2514574A1 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
EP2129381A1 (en) 2007-01-24 2009-12-09 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059987B1 (en) * 1979-06-01 1985-08-14 The Wellcome Foundation Limited Alpha-cyano-alpha-((n-guanidino)-imino) toluenes
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.

Also Published As

Publication number Publication date
PL325329A1 (en) 1998-07-20
NO980923L (no) 1998-05-04
AU6986596A (en) 1997-03-27
AP9600857A0 (en) 1996-10-31
HUP9901260A2 (hu) 1999-09-28
YU49796A (sh) 1999-07-28
CZ65598A3 (cs) 1998-07-15
ES2160834T3 (es) 2001-11-16
CO4750651A1 (es) 1999-03-31
CN1200729A (zh) 1998-12-02
US6124308A (en) 2000-09-26
NZ318390A (en) 1999-02-25
ATE203523T1 (de) 2001-08-15
HRP960399A2 (en) 1998-04-30
SK28598A3 (en) 1998-09-09
DE69614150D1 (de) 2001-08-30
KR19990044397A (ko) 1999-06-25
JPH11512108A (ja) 1999-10-19
AR004192A1 (es) 1998-11-04
TW367326B (en) 1999-08-21
WO1997009317A2 (en) 1997-03-13
GB9518027D0 (en) 1995-11-08
IS4673A (is) 1998-02-23
AU710091B2 (en) 1999-09-16
EA199800189A1 (ru) 1998-10-29
WO1997009317A3 (en) 1997-04-03
DE69614150T2 (de) 2001-11-22
BR9610388A (pt) 1999-07-06
ID17274A (id) 1997-12-18
IL123414A0 (en) 1998-09-24
AP640A (en) 1998-04-14
CA2230362A1 (en) 1997-03-13
TR199800386T1 (xx) 1998-05-21
MX9801680A (es) 1998-05-31
ZA967466B (en) 1998-04-06
BG102342A (en) 1998-09-30
BG65102B1 (bg) 2007-02-28
EP0879230A2 (en) 1998-11-25
HUP9901260A3 (en) 2001-04-28
EP0879230B1 (en) 2001-07-25
EA000695B1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
DK0753506T3 (da) 6-Dimethylaminomethyl-1-phenyl-cyclohexanforbindelser som farmaceutisk aktive stoffer
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
DK1930330T3 (da) Pleuromutilinderivater som antimikrobielle midler
NO973123D0 (no) Direkte komprimerbare, höykonsentrerte acetaminofenpreparater
DK0629616T3 (da) Optisk aktive 2-imidazolin-5-on-derivater som fungicider
DZ1966A1 (fr) Combinaison pharmaceutique nouvelle.
NO984106D0 (no) Azolobenzazepin-derivater som neurologisk aktive midler
NO20000231D0 (no) Dolastatin-15-derivater
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO980923D0 (no) Optisk aktivt fenylpyrimidin-derivat som analgetisk middel
NO974043D0 (no) Indolderivater som EAA-antagonister
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
NO975880L (no) Formylderivater anvendt som ikke-ioniske kontrastmidler
ITMI940506A0 (it) Derivati chinzolilamminici attivi come alfa-antagonisti
DE59505746D1 (de) Optisch aktive Tolan-Derivate
NO20005271L (no) Optisk aktive tetrahydrobenzindol-derivater
NO20012965D0 (no) Sulfonyloksazolaminer som terapeutisk aktive forbindelser
ATE187165T1 (de) Benzophenonhydrazon-derivate als insektizide
DK0763535T3 (da) Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser
DE60031509D1 (de) Optisch aktive fluorierte binaphthol-derivate
NO20002321D0 (no) Bifenylderivater som farmasøytiske midler
NO20000094L (no) 6-Azaurcilderivater som IL-5 inhibitorer
TR199601018A1 (tr) Farmasötik bilesikler.
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application